Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years

Fig. 2

Etiology and clinical course of Pneumocystis pneumonia (PcP). a Percentage of patients with respect to clinical course of PcP including organ replacement therapies (ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; RRT, renal replacement therapies) and outcomes. b Hospital mortality in different clinical settings (gray area highlights overall mortality). c Percentage of ICU admission and d percentage of ICU mortality with immunosuppression with different etiologies. The gray area shows the total percentage independent from the etiology. SOT, solid organ transplant; ChTx, chemotherapy; IS/RD, immunosuppression/rheumatic disease

Back to article page

Critical Care

ISSN: 1364-8535